Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Strang

Showing results (221-230 of 303) with videos related to

Pageof 31
Sort By:
Medical Physics|July 23, 2011
Crawling wave detection of prostate cancer: preliminary in vitro resultsLiwei An, Bradley Mills, Zaegyoo Hah, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 15, 2007
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politicsBenedikt Fischer, Eugenia Oviedo-Joekes, Peter Blanken, et al.
European Addiction Research|March 9, 2004
Does anyone care about names? How attendees at substance misuse services like to be addressed by health professionalsFrancis Keaney, John Strang, Jose Martinez-Raga, et al.
Psychiatric Genetics|September 15, 2015
Phenotypic heterogeneity in study populations may significantly confound the results of genetic association studies on alcohol dependenceM Adam Ali, Michael J Way, Michael Marks, et al.
Drug and Alcohol Dependence|June 27, 2016
DEVELOPMENT AND VALIDATION OF 'SURE': A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCEJoanne Neale, Silia Vitoratou, Emily Finch, et al.
The International Journal on Drug Policy|April 19, 2020
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative studyStephen Parkin, Joanne Neale, Caral Brown, et al.
Addiction (Abingdon, England)|April 8, 2025
Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principleMariana Gonzalez Utrilla, Edward Chesney, Joanne Neale, et al.
Drug and Alcohol Review|September 24, 2017
Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trialAngela Mary Meade, Sheila Macdonald Bird, John Strang, et al.
Contemporary Clinical Trials Communications|April 21, 2017
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trialSheila M Bird, John Strang, Deborah Ashby, et al.
Addiction (Abingdon, England)|April 20, 2018
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United KingdomMatthew Hickman, Colin Steer, Kate Tilling, et al.
Pageof 31

Showing results (221-230 of 303) with videos related to

Sort By:
Pageof 31
Medical Physics|July 23, 2011
Crawling wave detection of prostate cancer: preliminary in vitro resultsLiwei An, Bradley Mills, Zaegyoo Hah, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 15, 2007
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politicsBenedikt Fischer, Eugenia Oviedo-Joekes, Peter Blanken, et al.
European Addiction Research|March 9, 2004
Does anyone care about names? How attendees at substance misuse services like to be addressed by health professionalsFrancis Keaney, John Strang, Jose Martinez-Raga, et al.
Psychiatric Genetics|September 15, 2015
Phenotypic heterogeneity in study populations may significantly confound the results of genetic association studies on alcohol dependenceM Adam Ali, Michael J Way, Michael Marks, et al.
Drug and Alcohol Dependence|June 27, 2016
DEVELOPMENT AND VALIDATION OF 'SURE': A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCEJoanne Neale, Silia Vitoratou, Emily Finch, et al.
The International Journal on Drug Policy|April 19, 2020
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative studyStephen Parkin, Joanne Neale, Caral Brown, et al.
Addiction (Abingdon, England)|April 8, 2025
Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principleMariana Gonzalez Utrilla, Edward Chesney, Joanne Neale, et al.
Drug and Alcohol Review|September 24, 2017
Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trialAngela Mary Meade, Sheila Macdonald Bird, John Strang, et al.
Contemporary Clinical Trials Communications|April 21, 2017
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trialSheila M Bird, John Strang, Deborah Ashby, et al.
Addiction (Abingdon, England)|April 20, 2018
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United KingdomMatthew Hickman, Colin Steer, Kate Tilling, et al.
Pageof 31